The value of antimicrobial peptides in the age of resistance.

  title={The value of antimicrobial peptides in the age of resistance.},
  author={Maria Magana and Muthuirulan Pushpanathan and Ana L. Santos and Leon G Leanse and Michael Fern{\'a}ndez and Anastasios Ioannidis and Marc A. Giulianotti and Yiorgos Apidianakis and Steven B. Bradfute and Andrew L. Ferguson and Artem Cherkasov and Mohamed N. Seleem and Clemencia Pinilla and C{\'e}sar de la Fuente-Nunez and Themis Lazaridis and Tianhong Dai and Richard A. Houghten and Robert E. W. Hancock and George P Tegos},
  journal={The Lancet. Infectious diseases},

Figures and Tables from this paper

A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides

The therapeutic potential of peptide-based antimicrobials is detailed, as well as the challenges needed to overcome in order for clinical translation, and how this novel class of antimicrobial compound may address the need for effective antibiotics are explored.

Challenge in the Discovery of New Drugs: Antimicrobial Peptides against WHO-List of Critical and High-Priority Bacteria

The importance of antimicrobial peptides and their successful activity against critical and high-priority bacteria published in the WHO list is examined.

Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug‐resistant infections

The progress in synergistic studies on AMPs and conventional antibiotics and an overview of the current understanding of the functional scope of AMPs, ongoing clinical trials, and challenges in the development processes are presented.

Antimicrobial Peptide Mimics for Clinical Use: Does Size Matter?

Key and recent development in the field of small antimicrobial peptide mimics as a promising class of antimicrobials are highlighted, illustrating just how small you can go.

Antimicrobial peptides: mechanism of action, activity and clinical potential

This comprehensive review provides a broad overview of AMPs from the origin, structural characteristics, mechanisms of action, biological activities to clinical applications, and the strategies to optimize and develop AMP-based treatment as the potential antimicrobial and anticancer therapeutics.

Molecular engineering of antimicrobial peptides: microbial targets, peptide motifs and translation opportunities

It is argued that basic research advances constitute a solid basis for promising industry translation of rationally designed synthetic peptide antimicrobials, not only as novel drugs against multidrug-resistant strains but also as components of emerging antimicrobial biomaterials.

Targeting Multidrug Resistance With Antimicrobial Peptide-Decorated Nanoparticles and Polymers

This review presents the latest research progress made in the field of antimicrobial peptides, such as their mechanism of action, classification, application status, design techniques, and a review on decoration of nanoparticles and polymers with AMPs that are used in treating multidrug resistance.

Rational Framework for the Design of Trp- and Arg-Rich Peptide Antibiotics Against Multidrug-Resistant Bacteria

A rational framework is developed for systematically addressing the challenge of antibiotic resistance using libraries composed of 86 novel Trp- and Arg-rich engineered peptides tested against clinical strains of the most common multidrug-resistant bacteria known as ESKAPE pathogens and provides a path for a potential departure from the restriction to topical use of AMPs toward systemic application.

Incorporation of Non-Canonical Amino Acids into Antimicrobial Peptides: Advances, Challenges, and Perspectives

In this review, strategies for the incorporation of noncanonical amino acids into antimicrobial peptides, as well as their features and suitabilities are summarized.



Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics—A Novel Way to Combat Antibiotic Resistance?

Examination of a combined action of natural AMPs with different structure and mode of action with varied antibiotic agents found that synergy in antibacterial action mainly occurs between highly membrane-active AMPs and antibiotics with intracellular targets, suggesting bioavailability increase as the main model of such interaction.

Combating bacterial resistance by combination of antibiotics with antimicrobial peptides

This mini-review outlines some of the current and past work in combining AMPs with conventional antibiotics as strategies to address bacterial resistance.

Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance

This work indicates that evolution of resistance against certain AMPs, such as tachyplesin II and cecropin P1, is limited, and physicochemical features that make AMPs less prone to resistance and no cross- or horizontally-acquired resistance are found.

Antimicrobial Peptides: Diversity, Mechanism of Action and Strategies to Improve the Activity and Biocompatibility In Vivo

The diversity, history and the various mechanisms of action of AMPs are discussed, and some of the recent strategies developed to improve the activity and biocompatibility of AMP are reviewed.

Short Antimicrobial Peptides and Peptide Scaffolds as Promising Antibacterial Agents.

This paper reviews promising short, naturally-isolated or synthetic, antimicrobial peptides, along with their mimics, and discusses their merits as potential antibacterial agents.

Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides

The analysis of bacterial transcriptome may contribute to the understanding of microbial strategies under different environmental stresses and allows theUnderstanding of their interaction with novel AMPs, molecules which are wide-spread in all forms of life.

Alternative mechanisms of action of cationic antimicrobial peptides on bacteria

An updated review of how cationic antimicrobial peptides are able to affect bacterial killing, with a focus on internal targets is presented.